| Literature DB >> 36124035 |
Youfeng Guo1, Haihong Zhao1, Jiawei Lu1, Haowei Xu1, Tao Hu1, Desheng Wu1.
Abstract
Objective: This study was designed to determine whether lymphocyte to monocyte ratio (LMR) correlated with the intervertebral disc degeneration (IDD) severity and the postoperative spinal fusion rate in patients with lumbar disc disease.Entities:
Keywords: intervertebral disc degeneration; lymphocyte to monocyte ratio; prognostic factor; spinal fusion
Year: 2022 PMID: 36124035 PMCID: PMC9482412 DOI: 10.2147/JPR.S379453
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 2.832
Demographic Characteristics of Patients with Disc Degeneration Disease
| All | Low Score Group | High Score Group | ||
|---|---|---|---|---|
| (Cumulative Grade ≤ 18) | (Cumulative Grade > 18) | |||
| Subjects, n (%) | 303 | 167 (55.1) | 136 (44.9) | |
| Age, years | 67.00[57.00–72.00] | 63.00[51.00–69.00] | 69.00[63.00–75.00] | < 0.001 |
| Gender | 0.131 | |||
| Male, n (%) | 128(42.2) | 77(46.1) | 51(37.5) | |
| Female, n (%) | 175(57.8) | 90(53.9) | 85(62.5) | |
| BMI, kg/m2 | 24.83±3.55 | 25.14±3.67 | 24.45±3.38 | 0.092* |
| Smoking | 41(13.5) | 26(15.6) | 15(11.0) | 0.251 |
| Alcohol abuse | 25(8.3) | 13(7.8) | 12(8.8) | 0.744 |
| Lymphocyte, 109/L | 1.59[1.27–2.09] | 1.66[1.34–2.20] | 1.50[1.17–1.99] | 0.005 |
| Monocyte, 109/L | 0.46[0.36–0.56] | 0.44[0.36–0.54] | 0.47[0.36–0.58] | 0.290 |
| Neutrophils, 10^9/L | 3.52[2.67–4.71] | 3.48[2.73–4.59] | 3.57[2.58–4.78] | 0.969 |
| Hemoglobin, g/L | 131.90±16.56 | 133.54±16.98 | 129.89±15.86 | 0.056* |
| ESR, mm/H | 10.00[4.00–18.00] | 8.50[4.00–17.00] | 12.00[4.00–21.00] | 0.004 |
| LMR | 3.73[2.80–4.71] | 4.00[3.17–5.02] | 3.27[2.44–4.33] | < 0.001 |
| Albumin, g/L | 43.00[40.00–45.00] | 43.00[40.00–45.00] | 42.50[40.00–45.00] | 0.373 |
| Total serum protein, g/L | 67.51±5.18 | 67.39±5.17 | 67.65±5.20 | 0.658* |
| VAS | 4.00[3.00–6.00] | 4.00[3.00–5.00] | 4.00[3.00–6.00] | 0.123 |
| Hospital stay, day | 12.00[9.00–15.00] | 11.00[9.00–14.00] | 12.50[9.25–16.00] | 0.088 |
| Fusion | 202(66.7) | 121(72.5) | 81(59.6) | 0.018 |
| Hypertension | 142(46.9) | 64(38.3) | 78(57.4) | 0.001 |
| Diabetes mellitus | 54(17.8) | 29(17.4) | 25(18.4) | 0.818 |
| CHD | 39(12.9) | 26(15.6) | 13(9.6) | 0.120 |
| Osteoporosis | 110(36.3) | 51(30.5) | 59(43.4) | 0.021 |
| CT value | 128.30[96.00–163.70] | 136.70[103.30–174.30] | 117.15[88.48–148.83] | < 0.001 |
Notes: Normally distributed data are expressed as mean±SD and non-normally distributed data are expressed as the median (interquartile range). *Represents the t-test.
Abbreviations: BMI, body mass index; VAS, visual analogue scale; LMR, lymphocyte monocyte ratio; ESR, erythrocyte sedimentation rate; CHD, coronary heart disease.
The Pfirrmann Grading System for Lumbar Disc Degeneration
| 1 | 2 | 3 | 4 | 5 | |
|---|---|---|---|---|---|
| All (n = 303) | |||||
| L1/2 | 0 | 135(44.6) | 86(28.4) | 47(15.5) | 35(11.6) |
| L2/3 | 0 | 85(28.1) | 94(31.0) | 72(23.8) | 52(17.2) |
| L3/4 | 1(0.3) | 56(18.5) | 91(30.0) | 89(29.4) | 66(21.8) |
| L4/5 | 0 | 20 (6.6) | 80 (26.4) | 108 (35.6) | 95 (31.4) |
| L5/S1 | 0 | 26(8.6) | 53(17.5) | 87(28.7) | 137(45.2) |
| Low score group (n = 167) | |||||
| L1/2 | 0 | 112(67.1) | 41(24.6) | 10(6.0) | 4(2.4) |
| L2/3 | 0 | 82(49.1) | 67(40.1) | 16(9.6) | 2(1.2) |
| L3/4 | 1(0.6) | 56(33.5) | 77(46.1) | 31(18.6) | 2(1.2) |
| L4/5 | 0 | 20(12.0) | 63(37.7) | 68(40.7) | 16(9.6) |
| L5/S1 | 0 | 26(15.6) | 42(25.1) | 55(32.9) | 44(26.3) |
| High score group (n = 136) | |||||
| L1/2 | 0 | 23(16.9) | 45(33.1) | 37(27.2) | 31(22.8) |
| L2/3 | 0 | 3(2.2) | 27(19.9) | 56(41.2) | 50(36.8) |
| L3/4 | 0 | 0 | 14 (10.3) | 58 (42.6) | 64 (47.1) |
| L4/5 | 0 | 0 | 17(12.5) | 40(29.4) | 79(58.1) |
| L5/S1 | 0 | 0 | 11(8.1) | 32(23.5) | 93(68.4) |
Note: Values are expressed as n (%).
The Relationship Between the Severity of Individual Disc Degeneration and LMR
| LMR | p | ||
|---|---|---|---|
| L1/2 | pfirrmann grade < 4 | 3.86[2.89–4.93] | 0.019 |
| pfirrmann grade ≥ 4 | 3.35[2.60–4.27] | ||
| L2/3 | pfirrmann grade < 4 | 3.91[3.04–5.00] | 0.004 |
| pfirrmann grade ≥ 4 | 3.38[2.59–4.38] | ||
| L3/4 | pfirrmann grade < 4 | 4.10[3.17–5.00] | < 0.001 |
| pfirrmann grade ≥ 4 | 3.38[2.52–4.39] | ||
| L4/5 | pfirrmann grade < 4 | 3.92[3.06–4.99] | 0.083 |
| pfirrmann grade ≥ 4 | 3.66[2.70–4.53] | ||
| L5/S1 | pfirrmann grade < 4 | 4.09[3.16–4.61] | 0.239 |
| pfirrmann grade ≥ 4 | 3.63[2.73–4.81] |
Note: Values are expressed as the median (interquartile range).
Abbreviation: LMR, lymphocyte to monocyte ratio.
Correlation of LMR with Demographic and Clinical Parameters
| r/t | p | |
|---|---|---|
| Age | −0.285 | < 0.001 |
| Gender | −0.170* | < 0.001 |
| BMI | 0.079 | 0.171 |
| Smoking | 0.002* | 0.971 |
| Alcohol abuse | −0.055* | 0.241 |
| Neutrophils | −0.313 | < 0.001 |
| Hemoglobin | 0.153 | 0.007 |
| ESR | −0.067 | 0.282 |
| Hypertension | −0.114* | 0.015 |
| Diabetes mellitus | −0.015* | 0.750 |
| CHD | −0.050* | 0.284 |
| Osteoporosis | −0.071* | 0.131 |
| Albumin | 0.111 | 0.053 |
| Total serum protein | 0.096 | 0.095 |
| VAS | −0.107 | 0.063 |
| Hospital stay | −0.120 | 0.037 |
| CT value | 0.071 | 0.216 |
Note: *Represents Kendall’s correlation test.
Abbreviations: BMI, body mass index; VAS, visual analogue scale; LMR, lymphocyte monocyte ratio; ESR, erythrocyte sedimentation rate; CHD, coronary heart disease.
Figure 1Receiver operating characteristic (ROC) curve to determine the predictive performance of lymphocyte, monocyte, and LMR for severe degeneration (A) and spinal fusion (B).
Univariate and Multivariate Analysis Model 1 of Risk Factors for Severe Degeneration
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Age(year) | 1.075(1.050–1.102) | < 0.001 | 1.081(1.044–1.119) | < 0.001 |
| Gender(male) | 0.701(0.442–1.113) | 0.132 | 0.565(0.259–1.235) | 0.153 |
| BMI | 0.945(0.885–1.009) | 0.093 | 0.987(0.904–1.078) | 0.778 |
| Smoking | 0.672(0.340–1.327) | 0.253 | 1.048(0.393–2.796) | 0.925 |
| Alcohol abuse | 1.146(0.505–2.602) | 0.744 | 1.113(0.362–3.424) | 0.852 |
| LMR | 0.744(0.629–0.880) | 0.001 | 0.793(0.638–0.987) | 0.038 |
| Neutrophils | 1.036(0.924–1.163) | 0.541 | 0.924(0.779–1.097) | 0.368 |
| Hemoglobin | 0.987(0.973–1.000) | 0.058 | 1.014(0.991–1.037) | 0.241 |
| ESR | 1.031(1.010–1.052) | 0.003 | 1.021(0.989–1.054) | 0.192 |
| Hypertension | 2.164(1.365–3.433) | 0.001 | 1.265(0.639–2.507) | 0.500 |
| Diabetes mellitus | 1.072(0.594–1.934) | 0.818 | 1.098(0.477–2.524) | 0.826 |
| CHD | 0.573(0.282–1.164) | 0.124 | 0.199(0.078–0.506) | 0.001 |
| Osteoporosis | 1.743(1.086–2.796) | 0.021 | 0.743(0.386–1.430) | 0.373 |
| Albumin | 0.960(0.903–1.020) | 0.187 | 0.964(0.849–1.096) | 0.578 |
| Total serum protein | 1.010(0.967–1.055) | 0.657 | 1.028(0.940–1.037) | 0.542 |
Abbreviations: BMI, body mass index; LMR, lymphocyte monocyte ratio; ESR, erythrocyte sedimentation rate; CHD, coronary heart disease.
Figure 2Actual versus predicted severe degeneration (A) and spinal fusion failure (B) by risk deciles for models 1 and 5 (see Tables 5 and 6 for included variables). ROC curve analysis of prognostic models 1 (C) and 5 (D).
Univariate and Multivariate Analysis Model 5 of Risk Factors for Spinal Fusion Failure
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Age(year) | 1.028(1.008–1.049) | 0.006 | 1.024(0.993–1.057) | 0.132 |
| Gender(male) | 2.113(1.300–3.434) | 0.003 | 1.834(0.828–4.059) | 0.135 |
| BMI | 0.959(0.896–1.028) | 0.238 | 1.003(0.916–1.099) | 0.948 |
| Smoking | 1.333(0.676–2.627) | 0.407 | 0.546(0.179–1.668) | 0.288 |
| Alcohol abuse | 2.339(1.026–5.334) | 0.043 | 3.835(1.066–13.792) | 0.040 |
| LMR | 0.390(0.300–0.506) | < 0.001 | 0.371(0.258–0.532) | < 0.001 |
| Neutrophils | 1.118(0.993–1.259) | 0.065 | 0.935(0.762–1.147) | 0.519 |
| Hemoglobin | 0.992(0.978–1.007) | 0.280 | 0.982(0.957–1.007) | 0.164 |
| ESR | 0.999(0.981–1.018) | 0.957 | 0.977(0.947–1.008) | 0.141 |
| Hypertension | 1.244(0.771–2.008) | 0.371 | 0.760(0.354–1.631) | 0.481 |
| Diabetes mellitus | 0.812(0.428–1.541) | 0.525 | 0.795(0.305–2.072) | 0.638 |
| CHD | 1.000(0.490–2.041) | > 0.999 | 0.881(0.320–2.428) | 0.806 |
| Osteoporosis | 1.022(0.622–1.678) | 0.933 | 0.474(0.222–1.008) | 0.053 |
| Albumin | 0.940(0.882–1.002) | 0.058 | 0.927(0.807–1.065) | 0.284 |
| Total serum protein | 0.971(0.927–1.017) | 0.218 | 1.063(0.964–1.172) | 0.221 |
Abbreviations: BMI, body mass index; LMR, lymphocyte monocyte ratio; ESR, erythrocyte sedimentation rate; CHD, coronary heart disease.